Mirum develops and sells medicines for rare liver and other rare diseases, based in Foster City, California. It last closed at $91.95 on Nov 17, up 0.40% on the day. MIRM last reported earnings on Tue, Nov 3, 2026. The average 12-month price target from 10 analysts is $160.20 (+74.2% from the last close), with a high of $202.00 and a low of $130.00. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (10 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $719K, the largest $719K.
Each firm's latest rating on MIRM in the past 90 days
Average 12-month target
$160.20
▲ 74.2% upside
Based on 10 analysts who set a price target on MIRM in the past 90 days. The average target is $160.20, with a high of $202.00 and a low of $130.00, compared with the last close of $91.95.
Low $130.00Avg $160.20High $202.00
Blue marker: last close $91.95
Highest target$202.00
Average target$160.20
Lowest target$130.00
Latest rating changes
CitigroupTarget raised
Nov 11Buy$184 → $194
Leerink PartnersMaintained
Nov 5Buy$140
CitizensTarget raised
Nov 4Buy$137 → $167
HC Wainwright & Co.Target raised
Nov 4Buy$200 → $202
Cantor FitzgeraldMaintained
Nov 4Buy$160
Date
Firm
Action
Rating
Price target
Nov 11
Citigroup
Target raised
Buy
$184 → $194
Nov 5
Leerink Partners
Maintained
Buy
$140
Nov 4
Citizens
Target raised
Buy
$137 → $167
Nov 4
HC Wainwright & Co.
Target raised
Buy
$200 → $202
Nov 4
Cantor Fitzgerald
Maintained
Buy
$160
Loading…
Technical Analysis
MIRM · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend
The stock is 3% above its 20 day and 4% above its 50 day average. It is 7% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 55). The nearest support is the Pivot at $91.21, and the nearest resistance the Pivot R1 at $93.05.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityNormal, 4.2%/day
Key levels
$130.0052 week high+41.4%
$98.97Swing high (Nov 5)+7.6%
$98.51100 day average+7.1%
$98.29200 day average+6.9%
$93.05Pivot R1+1.2%
$91.95Last close
$91.21Pivot−0.8%
$90.59Swing low (Jun 3)−1.5%
$90.12Pivot S1−2.0%
$89.1520 day average−3.0%
$88.4550 day average−3.8%
$63.2352 week low−31.2%
Indicators
RSI (14)
54.87
Middle of its range
Neutral
MACD
1.84
Above its signal line
Bullish
Stochastic
59.8
Middle of its range
Neutral
ADX (14)
24.7
Weak trend
Williams %R
-44.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
34.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+5.7%
Change over 10 sessions
Bullish
ATR (14)
$3.82
Typical daily range, 4.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 9.6%/day
Key levels
$130.0052 week high+41.4%
$98.97Swing high (Nov 5)+7.6%
$98.51100 day average+7.1%
$98.29200 day average+6.9%
$93.05Pivot R1+1.2%
$91.95Last close
$91.21Pivot−0.8%
$90.59Swing low (Jun 3)−1.5%
$90.12Pivot S1−2.0%
$89.1520 day average−3.0%
$88.4550 day average−3.8%
$63.2352 week low−31.2%
Indicators
RSI (14)
48.11
Middle of its range
Neutral
MACD
-2.69
Below its signal line
Bearish
Stochastic
55.9
Middle of its range
Neutral
ADX (14)
17.6
No clear trend
Williams %R
-47.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-38.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.4%
Change over 10 sessions
Bearish
ATR (14)
$8.79
Typical daily range, 9.6% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Above
MA 200–
What happened before, for MIRM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MIRM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow MIRM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How MIRM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MIRM is in one of them and how their past MIRM trades turned out.
Mirum Pharmaceuticals is a biopharmaceutical company based in Foster City, California, that develops and sells medicines for rare diseases, mainly rare liver conditions. Its approved products are Livmarli, used to treat severe itching in certain rare cholestatic liver diseases, and Cholbam and Ctexli, used for bile acid disorders and a rare brain and tendon condition. It sells these medicines mainly in the United States and through partners in other countries, and it is developing treatments for other rare liver diseases and a rare genetic neurological disorder. Its customers include patients, physicians and specialty pharmacies.